- Home
- MTNB vs KXIN Comparison
MTNB vs KXIN Comparison
Compare MTNB & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- KXIN
- Stock Information
- Founded
- MTNB 2013
- KXIN 2015
- Country
- MTNB United States
- KXIN China
- Employees
- MTNB N/A
- KXIN N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- MTNB Health Care
- KXIN Consumer Discretionary
- Exchange
- MTNB Nasdaq
- KXIN Nasdaq
- Market Cap
- MTNB 3.0M
- KXIN 2.8M
- IPO Year
- MTNB N/A
- KXIN N/A
- Fundamental
- Price
- MTNB $0.58
- KXIN $1.42
- Analyst Decision
- MTNB Hold
- KXIN
- Analyst Count
- MTNB 1
- KXIN 0
- Target Price
- MTNB N/A
- KXIN N/A
- AVG Volume (30 Days)
- MTNB 1.0M
- KXIN 258.0K
- Earning Date
- MTNB 03-26-2025
- KXIN 01-01-0001
- Dividend Yield
- MTNB N/A
- KXIN N/A
- EPS Growth
- MTNB N/A
- KXIN N/A
- EPS
- MTNB N/A
- KXIN N/A
- Revenue
- MTNB N/A
- KXIN $12,679,000.00
- Revenue This Year
- MTNB N/A
- KXIN N/A
- Revenue Next Year
- MTNB N/A
- KXIN N/A
- P/E Ratio
- MTNB N/A
- KXIN N/A
- Revenue Growth
- MTNB N/A
- KXIN N/A
- 52 Week Low
- MTNB $0.48
- KXIN $1.20
- 52 Week High
- MTNB $21.50
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- MTNB 43.31
- KXIN 36.15
- Support Level
- MTNB $0.53
- KXIN $1.30
- Resistance Level
- MTNB $0.70
- KXIN $1.49
- Average True Range (ATR)
- MTNB 0.06
- KXIN 0.12
- MACD
- MTNB 0.00
- KXIN 0.03
- Stochastic Oscillator
- MTNB 13.92
- KXIN 14.95
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.